Processing
Processing. Please wait...

Amarin Probability Of Bankruptcy  

$1.92  0.00  0.00%
    
For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
95.56 %

About Probability Of Bankruptcy

Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin to competition

Amarin Probability Of Bankruptcy Assessment

Value  
Benchmark  Embed   Amarin Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 95%. This is 136.18% higher than that of the Healthcare sector, and 59.67% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 122.28% lower than the firm.

Filter other Stocks by Probability Of Bankruptcy

Select Probability Of Bankruptcy Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Found 10 equities

Probability Of Bankruptcy

NVO NYQNovo Nordisk AS
1.0%
TEVA NYQTeva Pharmaceutical Industries Limited
35.13%
ENDP NMSEndo International plc
39.11%
RDY NYQDr Reddys Laboratories Ltd
5.54%
UTHR NMSUnited Therapeutics Corporation
1.0%
ISIS NMSIsis Pharmaceuticals Inc
5.26%
TARO NYQTaro Pharmaceutical Industries Ltd
1.0%
DEPO NMSDepoMed Inc
15.48%
OREX NMSOrexigen Therapeutics Inc
26.39%
SCMP NGMSucampo Pharmaceuticals Inc
4.1%
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Chance of Financial Distress

Amarin Corporation plc has more than 95 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
SymbolAMRN
NameAmarin Corporation plc
InstrumentUSA Stock
Risk-adjusted AdviceStrong Sell Over Valued
CurrencyUSD - US Dollar
ExchangeNASDAQ General Markets
DescriptionAmarin Corporationration plc a biopharmaceutical company focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. more

Other Amarin Fundamentals

Return On Asset(28.32) %
Profit Margin(103.99) %
Operating Margin(177.03) %
Current Valuation451.26 M
Shares Outstanding174.59 M
Shares Owned by Insiders3.93 %
Shares Owned by Institutions33.30 %
Number of Shares Shorted25.67 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales6.38 times
Revenue54.2 M
Gross Profit33.72 M
EBITDA(95.11 M)
Net Income(56.36 M)
Cash and Equivalents119.54 M
Cash per Share0.69 times
Total Debt226.86 M
Current Ratio3.60 times
Book Value Per Share(0.51) times
Cash Flow from Operations(72.31 M)
Short Ratio2.60 times
One Year High3.33
One Year Low0.78
Earnings Per Share(0.36) times
Price to Earnings To Growth(0.04) times
Number of Employees201
Beta0.44
Market Capitalization322.99 M
Total Asset171.11 M
Retained Earnings(970.23 M)
Working Capital104.98 M
Current Asset145.28 M
Current Liabilities40.31 M
Z Score-6.4